Edward Fishman on Bloomberg: Global Energy Policy
Edward Fishman joins Bloomberg on October 30, 2025. Edward Fishman is one of the world’s foremost experts on economic statecraft, with deep experience shaping U.S.…
Thought Leader: Edward Fishman
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like.
Edward Fishman on Bloomberg: Global Energy Policy
Edward Fishman joins Bloomberg on October 30, 2025. Edward Fishman is one of the world’s foremost experts on economic statecraft, with deep experience shaping U.S.…
Thought Leader: Edward Fishman
4 Strategies Providers Are Using to Strengthen the Healthcare Workforce
During Reuters’ Total Health conference in Chicago, four healthcare leaders shared the strategies they believe will help fortify the workforce for the future. Healthcare’s workforce crisis continues…
Thought Leader: Dave Chokshi
Lisa Bodell: Smart Leaders Sabotage Their Own Strategies
Traditional strategic planning is often more of a ritual than a breakthrough moment. Teams gather, review last year’s metrics, and churn out a cookie-cutter annual…
Thought Leader: Lisa Bodell